ACOG
ACOG
NASDAQ · Biotechnology

Alpha Cognition Inc

$8.55
-0.01 (-0.12%)
Financial Highlights (FY 2026)
Revenue
12.85M
Net Income
-25,989,633
Gross Margin
81.3%
Profit Margin
-202.2%
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.3% 41.1% 41.1% 41.1%
Operating Margin -221.7% -6.9% -7.2% -7.2%
Profit Margin -202.2% -5.6% -6.7% -6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.85M 16.36M 16.49M 13.84M
Gross Profit 10.44M 6.72M 6.78M 5.68M
Operating Income -28,494,190 -1,134,163 -1,187,945 -993,114
Net Income -25,989,633 -919,800 -1,097,385 -862,011
Gross Margin 81.3% 41.1% 41.1% 41.1%
Operating Margin -221.7% -6.9% -7.2% -7.2%
Profit Margin -202.2% -5.6% -6.7% -6.2%
Rev Growth — +3.8% -10.0% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 45.89M 44.84M 56.68M
Total Equity — 37.49M 34.89M 41.83M
D/E Ratio — 1.22 1.29 1.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -28,466,106 -1,433,447 -1,263,705 -1,141,891
Free Cash Flow — -1,064,720 -1,173,966 -726,945